Adjuvant immunotherapy in muscle-invasive urothelial carcinoma

Alessandro Rizzo¹, Veronica Mollica¹, Francesco Massari²

Affiliations

¹ Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
² Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. Electronic address: francesco.massari@aosp.bo.it.

PMID: 34087146
DOI: 10.1016/S1470-2045(21)00202-3

Comment

Adjuvant immunotherapy in muscle-invasive urothelial carcinoma

Alessandro Rizzo et al. Lancet Oncol. 2021 Jun.

. 2021 Jun;22(6):e237.

doi: 10.1016/S1470-2045(21)00202-3.

Authors

Alessandro Rizzo¹, Veronica Mollica¹, Francesco Massari²

Affiliations

¹ Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
² Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy. Electronic address: francesco.massari@aosp.bo.it.

PMID: 34087146
DOI: 10.1016/S1470-2045(21)00202-3

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment in

Adjuvant immunotherapy in muscle-invasive urothelial carcinoma - Author's reply.
Bellmunt J. Bellmunt J. Lancet Oncol. 2021 Jun;22(6):e238. doi: 10.1016/S1470-2045(21)00298-9. Lancet Oncol. 2021. PMID: 34087147 No abstract available.

Comment on

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial.
Bellmunt J, Hussain M, Gschwend JE, Albers P, Oudard S, Castellano D, Daneshmand S, Nishiyama H, Majchrowicz M, Degaonkar V, Shi Y, Mariathasan S, Grivas P, Drakaki A, O'Donnell PH, Rosenberg JE, Geynisman DM, Petrylak DP, Hoffman-Censits J, Bedke J, Kalebasty AR, Zakharia Y, van der Heijden MS, Sternberg CN, Davarpanah NN, Powles T; IMvigor010 Study Group. Bellmunt J, et al. Lancet Oncol. 2021 Apr;22(4):525-537. doi: 10.1016/S1470-2045(21)00004-8. Epub 2021 Mar 12. Lancet Oncol. 2021. PMID: 33721560 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Adjuvant immunotherapy in muscle-invasive urothelial carcinoma

Affiliations

Adjuvant immunotherapy in muscle-invasive urothelial carcinoma

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources